ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,413.90
-0.51%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Ipsen SA (IPN)

  7. Ipsen SA (IPN) News

IPN Ipsen SA

113.00
0.70 (0.62%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ipsen SA IPN Euronext Ordinary Share
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.70 0.62% 113.00 01:40:00
Open Price Low Price High Price Close Price Previous Close
112.60 111.40 113.10 113.00 112.30
more quote information »

Recent News

Date Time Source Heading
24/4/202415:00GLOBEIpsen delivers strong sales in the first quarter of 2024,..
22/4/202415:00GLOBEIpsen et Skyhawk Therapeutics annoncent la signature d'un..
18/4/202402:00GLOBEIpsen publishes its 2023 Universal Registration Document
09/4/202402:00GLOBEIpsen - Information mensuelle relative au nombre total des..
02/4/202416:00GLOBEIpsen and Sutro Biopharma announce exclusive global..
08/3/202404:00GLOBEIpsen - Monthly information relative to the total number of..
15/2/202420:00GLOBEIpsen S.A. publishes its 2023 Consolidated Financial..
14/2/202408:08GLOBEIpsen reçoit l’approbation de la FDA pour le schéma..
08/2/202416:58GLOBEBuilding on solid FY 2023 results, Ipsen anticipates four..
07/2/202404:00GLOBEIpsen - Monthly information relative to the total number of..
23/1/202409:00GLOBEIpsen présente les dernières données d'un essai de Phase III..
09/1/202404:00GLOBEIpsen – Half year statement – 2023 12 31
06/1/202404:00GLOBEIpsen - Monthly information relative to the total number of..
08/12/202304:49GLOBEIpsen - Information mensuelle relative au nombre total des..
07/12/202317:00GLOBEJournée Investisseurs 2023 - Ipsen présente sa prochaine..
15/11/202304:00GLOBEIPSEN - Buy-back programme - Art 5 of MAR - Week 45 - 2023
14/11/202308:30GLOBEResults from Ipsen’s ELATIVE® pivotal Phase III trial of..
08/11/202304:00GLOBEIPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2023
07/11/202304:00GLOBEIpsen - Monthly information relative to the total number of..
01/11/202323:35GLOBEInternational companies to host live webcasts at Deutsche..
01/11/202304:00GLOBEIPSEN - Achats effectués dans les conditions de l'Article 5..
26/10/202316:00GLOBEIpsen delivers solid sales growth in the first nine months..
25/10/202303:00GLOBEIPSEN - Achats effectués dans les conditions de l'Article 5..
23/10/202316:00GLOBEIpsen fait le point sur la demande d’Autorisation de Mise..
18/10/202303:00GLOBEIPSEN - Buy-back programme - Art 5 of MAR - Week 41 - 2023
11/10/202303:00GLOBEIPSEN - Achats effectués dans les conditions de l'Article 5..
07/10/202303:00GLOBEIpsen - Information mensuelle relative au nombre total des..
04/10/202303:00GLOBEIPSEN - Achats effectués dans les conditions de l'Article 5..
27/9/202302:00GLOBEIPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2023
20/9/202302:00GLOBEIPSEN - Achats effectués dans les conditions de l'Article 5..
13/9/202302:00GLOBEIPSEN - Buy-back programme - Art 5 of MAR - Week 36 - 2023
09/9/202302:00GLOBEIpsen - Information mensuelle relative au nombre total des..
06/9/202302:00GLOBEIPSEN - Achats effectués dans les conditions de l'Article 5..
04/9/202315:00GLOBEIpsen nomme Pascal Touchon en tant que nouvel administrateur..
01/9/202315:00GLOBEIpsen annonce un changement à la direction de sa R&D :..
30/8/202302:00GLOBEIPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2023
23/8/202302:00GLOBEIPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2023
21/8/202315:00GLOBEExelixis et Ipsen annoncent les résultats positifs de..
17/8/202305:32GLOBELes autorités réglementaires américaines (FDA) approuvent le..
16/8/202319:50GLOBEIPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2023
09/8/202302:00GLOBEIPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2023
05/8/202302:00GLOBEIpsen - Information mensuelle relative au nombre total des..
02/8/202302:00GLOBEIPSEN - Achats effectués dans les conditions de l'Article 5..
28/7/202302:06GLOBEIpsen S.A. publishes its 2023 Half-Year Financial Report
27/7/202315:00GLOBEIpsen delivers solid H1 2023 results and upgrades its..
26/7/202302:00GLOBEIPSEN - Achats effectués dans les conditions de l'Article 5..
24/7/202315:00GLOBEIpsen annonce la simplification du concert entre ses..
21/7/202322:52GLOBECorrection: Ipsen provides update on E.U. Marketing..
21/7/202321:52GLOBEIpsen provides update on E.U. Marketing Authorization..
20/7/202302:42GLOBEIpsen annonce la décision de la Commission européenne (CE)..

Your Recent History

EU
IPN
Ipsen
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved